Viewing Study NCT04145232


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-05-25 @ 12:01 PM
Study NCT ID: NCT04145232
Status: UNKNOWN
Last Update Posted: 2020-08-10
First Post: 2019-10-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.
Sponsor: Ardigen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
None Neoepitopes View
None Neoantigens View
None Immunotherapy View
None Next Generation Sequencing (NGS) View
None Personalized Neoantigen Cancer Vaccine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Non Small Cell Lung Cancer View
None Neoepitopes View
None Neoantigens View
None Immunotherapy View
None Nivolumab View
None Ipilimumab View
None Atezolizumab View
None Neoantigen cancer vaccine View
None Personalized neoantigen cancer vaccine View
None FFPE View
None PBMC View
None Stool View
None Immuno-Oncology View
None Next generation sequencing (NGS) View